课题基金 / 基金详情

项目摘要

项目成果

Harris Bernstein的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Members of the genus Bacteroides are by far the most abundant Gram-negative bacteria in the human gut microbiome. We used mass spectrometry to examine the outer membrane (OM) proteome and secretome of one of the most commonly studied members of the Bacteroides genus, B. fragilis, grown under laboratory conditions. Although we did not identify any novel secretion pathways, we found that this organism uses a very different range of secretion strategies than Proteobacteria such as E. coli. B. fragilis lacks many of the pathways that are widespread among the Protebacteria (e.g., the type II, III and IV pathways) but produces multiple type I secretion systems simultaneously. The substrates of the type I pathways are unknown and cannot be easily predicted based on homology to proteins that are type I substrates in Proteobacteria. B. fragilis also differs dramatically from Proteobacteria in that it produces a large number of lipoproteins that are exposed on the cell surface. We are currently using a variety of methods to investigate the mechanism(s) by which lipoproteins are transported across the OM and to identify targeting signals that earmark specific lipoproteins for export. Interestingly, many of the proteins found in the secretome lack significant homology to proteins that are in the Genbank database and presumably have novel functions. In a recent study we examined the function of fragipain, a poorly characterized clostripain-like protease that is exposed on the cell surface of B. fragilis. Surprisingly, we found that disruption of the gene that encodes this protein (fpn) led to a strong reduction in the level of >100 proteins, many of which are predicted to be lipoproteins, in the secretome. Experiments performed with purified fragipain provided direct evidence that the protease releases at least some of these proteins from the cell surface. The observation that wild-type cells outcompeted an fpn- strain in co-cultivation assays also supported the notion that fragipain plays an important role in cell physiology. Finally, we found that purified fragipain altered the adhesive properties of HT29 intestinal epithelial cells. Our results suggest that fragipain is a broad-spectrum protease that not only catalyzes protein secretion on a wide scale but that also potentially cleaves host cell proteins during colonization.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/mmi.14616
发表时间: 2021-03
期刊: MOLECULAR MICROBIOLOGY
影响因子: 3.6
作者: [Pierce, Jessica V., Fellows, Justin D., Anderson, D. Eric, Bernstein, Harris D.]
通讯作者: Bernstein, Harris D.
DOI: 10.1371/journal.pone.0158171
发表时间: 2016
期刊: PloS one
影响因子: 3.7
作者: [Pierce JV, Bernstein HD]
通讯作者: Bernstein HD
Analysis of the outer membrane proteome and secretome of Bacteroides fragilis reveals a multiplicity of secretion mechanisms.
对脆弱拟杆菌外膜蛋白质组和分泌组的分析揭示了多种分泌机制。
DOI: 10.1371/journal.pone.0117732
发表时间: 2015
期刊: PloS one
影响因子: 3.7
作者: [Wilson MM, Anderson DE, Bernstein HD]
通讯作者: Bernstein HD
DOI: 10.1016/j.tim.2015.11.006
发表时间: 2016-03
期刊: TRENDS IN MICROBIOLOGY
影响因子: 15.9
作者: [Wilson, Marlena M., Bernstein, Harris D.]
通讯作者: Bernstein, Harris D.
Translational regulation in the ribosome tunnel
Biogenesis of bacterial autotransporter proteins
Translational regulation in the ribosome tunnel
Biogenesis of bacterial outer membrane proteins
国内基金
海外基金
肠道菌群Bacteroides uniformis通过PGA-GSS/GSH通路调控近视发展的机制研究
  • 批准号:
    2026JJ50567
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    文丹
  • 依托单位:
Bacteroides fragilis通过3-oxoLCA诱导FBXO38介导的PD-1泛素化降解改善结直肠癌免疫治疗效果的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    邵欣宇
  • 依托单位:
肠道共生菌Bacteroides acidifaciens通过调节甘氨胆酸代谢作用于酒精性肝病的机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    吴震州
  • 依托单位:
孕前高脂饮食导致子代 Bacteroides 丢失协同 肠道菌群及肠道屏障发育异常的机制研究
  • 批准号:
    TGY24H260012
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    金萃媛
  • 依托单位: